Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan

NCT01389687 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Poliomyelitis
Polio

Interventions

BIOLOGICAL: Inactive Poliovirus Vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company